TScan Therapeutics, Inc. (TCRX)
NASDAQ: TCRX · Real-Time Price · USD
1.240
+0.120 (10.71%)
At close: Mar 9, 2026, 4:00 PM EDT
1.220
-0.020 (-1.61%)
After-hours: Mar 9, 2026, 7:27 PM EDT
TScan Therapeutics Market Cap
TScan Therapeutics has a market cap or net worth of $70.56 million as of March 9, 2026. Its market cap has decreased by -42.98% in one year.
Market Cap
70.56M
Enterprise Value
12.29M
1-Year Change
-42.98%
Ranking
Category
Stock Price
$1.24
Market Cap Chart
Since the IPO on July 16, 2021, TScan Therapeutics's market cap has decreased from $359.08M to $70.56M, a decrease of -80.35%. That is a compound annual growth rate of -29.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 63.73M | 12.30% |
| Dec 31, 2025 | 56.75M | -66.96% |
| Dec 31, 2024 | 171.78M | -38.39% |
| Dec 29, 2023 | 278.82M | 647.03% |
| Dec 30, 2022 | 37.32M | -65.09% |
| Dec 31, 2021 | 106.93M | -70.22% |
| Jul 16, 2021 | 359.08M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cingulate | 66.99M |
| MediciNova | 66.94M |
| Actuate Therapeutics | 66.48M |
| Annovis Bio | 65.99M |
| InflaRx | 65.71M |
| Q32 Bio | 65.66M |
| Mereo BioPharma Group | 62.71M |
| ImageneBio | 62.20M |